_version_ 1797632746720329728
author Yan Zhang
Michael Peel
Adrian Bot
Brittany Ross
Duy Nguyen
Michelle Nguyen
Theresa Hunter
Gregor Adams
Barzan A Sadiq
Haig Aghajanian
Ferran Soldevila
Daiki Matsuda
Yanjie Bao
Stuart A Sievers
John Li
Josephine Nguyen
Claudia Fernandez
Yi Kuo
James Vestal
Matthew Butcher
Jeffrey Chen
Stanley Zhang
Makan Khoshnejad
Donald Jhung
Steve Tanis
Michael Rosenzweig
Priya Karmali
author_facet Yan Zhang
Michael Peel
Adrian Bot
Brittany Ross
Duy Nguyen
Michelle Nguyen
Theresa Hunter
Gregor Adams
Barzan A Sadiq
Haig Aghajanian
Ferran Soldevila
Daiki Matsuda
Yanjie Bao
Stuart A Sievers
John Li
Josephine Nguyen
Claudia Fernandez
Yi Kuo
James Vestal
Matthew Butcher
Jeffrey Chen
Stanley Zhang
Makan Khoshnejad
Donald Jhung
Steve Tanis
Michael Rosenzweig
Priya Karmali
author_sort Yan Zhang
collection DOAJ
first_indexed 2024-03-11T11:41:12Z
format Article
id doaj.art-19b7b54c372d4f1982326821a2571052
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T11:41:12Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-19b7b54c372d4f1982326821a25710522023-11-10T03:30:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.12021202 In vivo engineering of CAR T cells using a novel targeted LNP-mRNA technologyYan Zhang0Michael Peel1Adrian Bot2Brittany Ross3Duy Nguyen4Michelle Nguyen5Theresa Hunter6Gregor Adams7Barzan A Sadiq8Haig Aghajanian9Ferran Soldevila10Daiki Matsuda11Yanjie Bao12Stuart A Sievers13John Li14Josephine Nguyen15Claudia Fernandez16Yi Kuo17James Vestal18Matthew Butcher19Jeffrey Chen20Stanley Zhang21Makan Khoshnejad22Donald Jhung23Steve Tanis24Michael Rosenzweig25Priya Karmali262Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA1University of Florida, Gainesville, FL, USAArsenal Biosciences, South San Francisco, CA, USA2Capstan Therapeutics, San Diego, CA, USAImPACT-Bio, Rehovot, Israel2Capstan Therapeutics, San Diego, CA, USA3Capstan Therapeutics, Philadelphia, PA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA2Capstan Therapeutics, San Diego, CA, USA
spellingShingle Yan Zhang
Michael Peel
Adrian Bot
Brittany Ross
Duy Nguyen
Michelle Nguyen
Theresa Hunter
Gregor Adams
Barzan A Sadiq
Haig Aghajanian
Ferran Soldevila
Daiki Matsuda
Yanjie Bao
Stuart A Sievers
John Li
Josephine Nguyen
Claudia Fernandez
Yi Kuo
James Vestal
Matthew Butcher
Jeffrey Chen
Stanley Zhang
Makan Khoshnejad
Donald Jhung
Steve Tanis
Michael Rosenzweig
Priya Karmali
1202 In vivo engineering of CAR T cells using a novel targeted LNP-mRNA technology
Journal for ImmunoTherapy of Cancer
title 1202 In vivo engineering of CAR T cells using a novel targeted LNP-mRNA technology
title_full 1202 In vivo engineering of CAR T cells using a novel targeted LNP-mRNA technology
title_fullStr 1202 In vivo engineering of CAR T cells using a novel targeted LNP-mRNA technology
title_full_unstemmed 1202 In vivo engineering of CAR T cells using a novel targeted LNP-mRNA technology
title_short 1202 In vivo engineering of CAR T cells using a novel targeted LNP-mRNA technology
title_sort 1202 in vivo engineering of car t cells using a novel targeted lnp mrna technology
work_keys_str_mv AT yanzhang 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT michaelpeel 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT adrianbot 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT brittanyross 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT duynguyen 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT michellenguyen 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT theresahunter 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT gregoradams 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT barzanasadiq 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT haigaghajanian 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT ferransoldevila 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT daikimatsuda 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT yanjiebao 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT stuartasievers 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT johnli 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT josephinenguyen 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT claudiafernandez 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT yikuo 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT jamesvestal 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT matthewbutcher 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT jeffreychen 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT stanleyzhang 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT makankhoshnejad 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT donaldjhung 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT stevetanis 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT michaelrosenzweig 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology
AT priyakarmali 1202invivoengineeringofcartcellsusinganoveltargetedlnpmrnatechnology